BioSpace News Archive

MedCerts, one of the nation’s leading providers of online career certification training, announces today the addition of Kelly Hover, former University of Phoenix Director, to its executive team.

The National Organization for Rare Disorders (NORD)®, the leading independent nonprofit organization representing over 25 million Americans living with rare diseases, is issuing a Rare Disease Day decree: Show Your Stripes!

OrbiMed Advisors LLC (“OrbiMed”), on behalf of its clients, has evaluated the Joint Proxy Statement/Prospectus for the proposed merger of Foamix Pharmaceuticals Ltd. (“Foamix”) and Menlo Therapeutics Inc. (“Menlo”).

Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., one of the world’s leading companies in the diagnostic imaging business, does not comment on pending litigations per its corporate policy.

WebMD Health Services today announced the launch of WebMD ONE Health Plan and WebMD One Senior and WebMD ONE Health Plan, two new programs that build on WebMD ONE’s digital platform of innovative well-being solutions for employers and health plan participants.

UH partnered with GOJO on the study that eliminated influenza, MRSA and VRE through an Infection Risk Reduction Program

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced that it has obtained approval of Dovato (dolutegravir 50 mg/lamivudine 300 mg) from the Japan Ministry of Health, Labour and Welfare (MHLW) for the treatment of HIV-1 infection in adults and adolescents above 12 years of age weighing at least 40 kg

Urania Therapeutics announces today that it will benefit from €1.7 million ($1.9M) Deeptech financing from Bpifrance in addition to its recent seed funding round.

FDA working with manufacturer to assess scope of potential contamination risk, possible supply chain disruptions

Warrant holders will continue to be able to exercise their Warrants on a cash basis as well.